Indrayani Biotech Clarifies Price Movement Due to Upcoming Rights Issue Committee Meeting and Potential Demerger

Indrayani Biotech Ltd has provided a clarification regarding the recent price movement of its shares. The company attributes the movement to the market's reaction to two recent statutory intimations. The first is about the meeting of the Rights Issue (RI) Committee to discuss the ongoing Rights Issue process. The second is about an upcoming Board Meeting to discuss a potential demerger of the company’s food business into a separate company. The company assures that there is no undisclosed information or impending announcement that could affect the price or volume behavior of the scrip.